Status:
COMPLETED
tSCI Contrast Enhanced Ultrasound Study
Lead Sponsor:
University of Washington
Conditions:
Acute Spinal Cord Injury
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Patients with traumatic spinal cord injury (tSCI) often suffer from spinal cord swelling inside the thecal sac, which contains the spinal cord and surrounding fluid, leading to increased pressure on t...
Detailed Description
Patients presenting to the Harborview Emergency Room with acute traumatic spinal cord injury (tSCI) will be recruited to undergo contrast-enhanced ultrasound (CEUS) during routine surgery for decompre...
Eligibility Criteria
Inclusion
- \>18
- Male or Female
- Acute \<72 hours spinal cord injury (ASIA) grade A to D
- Medically stable to undergo routine decompression and spinal realignment
Exclusion
- \<18 years of age
- Not clinically stable for spinal surgery
- Traumatic Brain Injury
- Known sensitivity to lipid microsphere or its components i.e., (PEG).
- A history of anaphylactoid reactions from ultrasound-enhancing agents
Key Trial Info
Start Date :
July 31 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 20 2023
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT04056988
Start Date
July 31 2018
End Date
November 20 2023
Last Update
July 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Harborview Medical Center
Seattle, Washington, United States, 98104